semaglutide injection fda approval US approves weight loss drug Wegovy to prevent cardiovascular events FDA approves obesity drug that

By the studys end, liraglutide had elevated testosterone and SHBG to higher levels than achieved in the other groups and led to higher sperm counts and motility, earning the authors conclusion that liraglutide is a useful drug for the treatment of obese males with metabolic hypogonadism, outperforming traditional hormonal approaches This pioneering trial suggests that tackling the root cause (obesity/insulin resistance) with a GLP-1 RA can reverse obesity-related hypogonadism and improve fertility potential in men

Although some men may experience temporary side effects such as nausea, vomiting, diarrhea, abdominal pain, constipation, heartburn, and burping, these symptoms typically resolve within the first month

People should not take Semaglutide if they have a family or personal history of certain cancers, pancreatitis, gallbladder problems, or certain other medical problems

But the gastrointestinal effects scale with concentration too

Today, Tirzepatide remains a major subject of investigation in metabolic science, endocrinology, obesity research, and cardiometabolic studies